BGI

BGI Group

Brief company and industry description
BGI Group — a Chinese company founded in 1999, one of the world leaders in genomics and biotechnology. Its activities span research, production, and application of genomic data, making it a key player in the "omics" sector and precision medicine.

Main products/services and key markets

• Services: DNA/RNA sequencing, metagenomics, diagnostics of hereditary and oncological diseases.
• Products: sequencing platforms (e.g., DNBSeq), prenatal tests, diagnostic kits.
• Key markets: healthcare, research centers, agricultural biotechnology; operations span more than 100 countries.

Year of foundation, revenue, number of employees, presence by country

• Founded: 1999.
• Revenue: approximately 251 million USD (2016 data)
• Number of employees: approximately 10,000 people worldwide.
• Presence: offices, laboratories, and production facilities in more than 100 countries and regions.

What makes their office/plant/production interesting, what can be seen and understood about the business
BGI's infrastructure integrates high-throughput genomic sequencing laboratories with digital analysis platforms and diagnostic kit production. This demonstrates a complete cycle — from research and development to industrial production and global application. Visiting the company's facilities allows one to see how genomic technologies become commercial solutions and enable international presence.